Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 50× · first seen 08-sep-2026 · last seen 10-nov-2026

Rapamycin and mTOR Inhibition

Current understanding

The most robust animal-lifespan drug result; human dosing trials (e.g. intermittent low-dose) are early.

Evidence log

Open questions

Related

Contributing findings

pubmed observational human-observational
Rapamycin and human longevity among kidney transplant recipients surviving the first year.
05-nov-2026 novelty 4 per-area 4 strengthens
pubmed review
Age: a modifiable risk factor for cardiovascular disease?
02-nov-2026 novelty 2 per-area 1 mentions
pubmed preclinical animal-model
Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1-Dependent Suppression of ROMK.
01-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro-Inflammatory Gene Expression in Skeletal Muscle of Aged Mice.
01-nov-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
09-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Is there a role for senotherapeutics in the treatment of giant cell arteritis?
07-oct-2026 novelty 2 per-area 2 mentions
pubmed preclinical animal-model
Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions.
06-oct-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials.
05-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain.
05-oct-2026 novelty 2 per-area 2 strengthens
rss news report
Fight Aging! Newsletter, October 5th 2026
04-oct-2026 novelty 2 per-area 2 mentions
pubmed preclinical animal-model
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Berberine as a multi-hallmark modulator of aging: From AMPK and mitophagy to inflammaging and the SASP.
28-sep-2026 novelty 2 per-area 2 mentions
pubmed review
Rapamycin across biology and medicine: From molecular mechanisms to clinical and translational frontiers.
24-sep-2026 novelty 2 per-area 2 strengthens
rss preclinical animal-model
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice
23-sep-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Lsp2 links mTORC1 to TOP mRNA translation and lifespan in Drosophila.
23-sep-2026 novelty 4 per-area 4 strengthens
pubmed observational
Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories.
22-sep-2026 novelty 3 per-area 2 mentions
pubmed review
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review.
19-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes.
19-sep-2026 novelty 2 per-area 2 strengthens
clinicaltrials trial early expert-opinion
A Nutritional and Pharmacological Intervention for Body, Brain, and Longevity Effects (NIBBLE)
16-sep-2026 novelty 3 per-area 3 strengthens
pubmed trial early human-rct
EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.
10-sep-2026 novelty 3 per-area 3 strengthens
pubmed review
Immunosenescence, inflammaging, and metabolic disease: A geroscience perspective on mechanisms and links.
10-sep-2026 novelty 2 per-area 2 mentions
pubmed preclinical
Copper and iron engage distinct metabolic programs for cellular survival.
09-sep-2026 novelty 3 per-area 2 mentions
rss news report
The Challenge of Cheap Interventions and Expensive Clinical Trials
07-sep-2026 novelty 2 per-area 2 mentions
pubmed preclinical
LivAge: An Online Aging Clock for Murine Transcriptomic Age Estimation.
01-sep-2026 novelty 3 per-area 2 strengthens
pubmed review
A Mechanism-Based Framework for Anti-Aging Strategies: From Metabolic Regulation to Senotherapy and Stem Cell-Based Interventions.
01-sep-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early expert-opinion
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
27-aug-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1α-mediated metabolic dysregulation.
26-aug-2026 novelty 3 per-area 3 strengthens
pubmed review
Thymus regeneration in countering immunosenescence: Mechanisms, strategies and future perspectives.
13-aug-2026 novelty 2 per-area 2 strengthens
pubmed review
High-fructose diet-induced gut dysbiosis as a mechanistic driver of chronic inflammation and accelerated biological aging: a comprehensive review.
13-aug-2026 novelty 2 per-area 2 mentions
pubmed review
Review: The African turquoise killifish as a model for the integrative physiology of vertebrate aging.
11-aug-2026 novelty 2 per-area 2 mentions
pubmed review mechanism-plausible
Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives.
11-aug-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
Senescent cardiac cells promote thrombus formation and impair fibrinolysis.
01-aug-2026 novelty 3 per-area 3 strengthens
pubmed other mechanism-plausible
A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health.
01-aug-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.
01-aug-2026 novelty 4 per-area 4 strengthens
pubmed review
Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.
27-jul-2026 novelty 2 per-area 2 mentions
pubmed review
Senomorphic agents: Multi-target strategies to tame the senescence-associated secretory phenotype for healthy ageing.
24-jul-2026 novelty 2 per-area 2 mentions
pubmed review
Chasing the FoxO in Metabolic Disorders: Novel Considerations for Oxidative Stress, Programmed Cell Death, Wnt, and the Gut Microbiome.
20-jul-2026 novelty 2 per-area 2 mentions
pubmed preclinical animal-model
Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance.
17-jul-2026 novelty 3 per-area 3 strengthens
pubmed review
Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways.
16-jul-2026 novelty 2 per-area 1 mentions
pubmed review
Biological limits of lifespan extension: Evidence for a shift from pathway leverage to system-level buffering across species.
12-jul-2026 novelty 3 per-area 2 weakens
pubmed review
Effects of nutritional interventions on biomarkers of cellular senescence in humans: A systematic review.
04-jul-2026 novelty 3 per-area 2 strengthens
pubmed observational animal-model
Mammalian aging involves genome-wide splicing degeneration leading to functional decline.
29-jun-2026 novelty 3 per-area 3 strengthens
pubmed review
From lifespan extension to hallmark-informed gerotherapeutic prioritization: A bibliometric-guided, strategy-oriented review of anti-aging drug research.
28-jun-2026 novelty 3 per-area 2 strengthens
pubmed review
Orchestration of Autophagy and Senescence: Kinases Take the Center Stage.
28-jun-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early expert-opinion
The Role of Sirolimus in Preventing Functional Decline in Older Adults
25-jun-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early
MTOR Inhibitors in Older Adults
25-jun-2026 novelty 2 per-area 2 strengthens
pubmed review
Biomarkers and therapies associated with Hutchinson-Gilford Progeria Syndrome.
17-jun-2026 novelty 2 per-area 2 mentions
pubmed review
Autophagy decline during ageing: Molecular regulation, tissue specificity, and therapeutic potential.
30-may-2026 novelty 2 per-area 2 strengthens
pubmed preclinical mechanism-plausible
Feedback loops between DNMT1 and autophagy as well as senescence promotes organ aging and canities.
28-may-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
Discrimination of normal from slow-aging mice by plasma metabolomic and proteomic features.
15-dec-2025 novelty 3 per-area 2 mentions

build build 880 · 2bcef25 · 2026-11-18